Abstract: A container having multiple wall panels forming container sides, the container having at least first and second wall panels that meet at a first corner. The container is assembleable from a flat or knockdown state to an opened or assembled state. A first inner panel is attached to a first wall panel, the first inner panel having an end spaced from the first corner. A slidable corner support is attached to the end of the first inner panel and extends towards the second wall panel. When the container is assembled from the knockdown state, the slidable corner support moves away from the first corner to form a support member that can help support a container stacked on top and prevent nesting.

Abstract: The current invention encompasses a microemulsion having environmentally safe components, the microemulsion exhibiting optical clarity and stability over a wide range of temperatures. The microemulsion also forms a part of a decontaminant solution for treating chemical and biological contaminant agents, the solution preferably containing peroxycarboxylic acids generated from solids as the primary decontamination agent. The solution is a single phase emulsion that is both stable and effective over a broad range of temperatures, the range extending well below 0° C. There is also disclosed a microemulsion decontaminate solution having components that stabilize the included solid and peroxycarboxylic acids.

Abstract: The present invention provides for reagents for the introduction of colorimetric-oxycarbonyl protecting groups, compounds bearing colorimetric-oxycarbonyl protecting groups, and the use thereof in solid-supported organic syntheses of oligonucleotides, polypeptides, polysaccharides, and combinatorial libraries.

Abstract: A halogenated elastomer partially functionalized with triethylamine, in a mixture with fiiier and a cure package, suitable for use as an air barrier in an innertube or tire innerliner, is disclosed. The halogenated elastomer can be a polymer comprising C4 to C7 isoolefm derived units, para-alkylstyrene derived units, para-(haloalkylstyrene) derived units, and para-(triethylammoniumalkylstyrene) derived units. The Mooney viscosity of the elastomer can be controlled by the degree of triethylamine functionalization. Also disclosed is a method for making an article using the tri ethy iamine-functionalized elastomer.

Abstract: A method and device are provided to generate an aerosol having a desired particle sizes, i.e., from molecular to about 10 microns, which can be used to effectively deliver a physiologically active compound to organs and tissues such as the lung, eye, mucosa and skin. The aerosol is formed through vaporization of the compound while mixing the resulting vapor with a gas, in a ratio, to form the desired particle size when a stable concentration of particles in the gas is reached.

Abstract: The current invention encompasses a microemulsion having environmentally safe components, the microemulsion exhibiting optical clarity and stability over a wide range of temperatures. The microemulsion also forms a part of a decontaminant solution for treating chemical and biological contaminant agents, the solution preferably containing peroxycarboxylic acids generated from solids as the primary decontamination agent. The solution is a single phase emulsion that is both stable and effective over a broad range of temperatures, the range extending well below 0° C. There is also disclosed a microemulsion decontaminate solution having components that stabilize the included solid and peroxycarboxylic acids.

Abstract: A method of attaching a solder element to a contact and the contact assembly formed thereby. The contact assembly is used in a connector. The solder element is either staked or stapled to the contact. The solder element can take a variety of shapes and disclosed herein is a tear-drop shape, a “wolf's head” shape and a circular shape. An over-stress feature is also provided for when the contact assembly is mounted to a printed wiring board.

Abstract: The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. In a method aspect of the present invention, a method of forming an aerosol for use in inhalation therapy is provided. The method involves the following steps: (a) heating a substrate coated with a composition comprising a drug at a rate greater than 1000° C./s, thereby forming an vapor; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another method aspect of the present invention, a method of forming an aerosol for use in inhalation therapy is provided. The method involves the following steps: (a) heating a substrate coated with a composition comprising a drug to form a vapor, wherein the coated composition is in the form of a film less than 10? thick; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy.

Abstract: An electric machine includes a fluid control system that is configured to regulate the flow rate of fluid to the electric machine. The machine includes a sensor that senses a parameter representative of cooling required by the machine. The sensor supplies a sensor signal to a control unit, which in turn supplies a flow control signal to a flow regulator. The flow regulator, in response to the flow control signal, controls the flow rate of fluid to the machine to what is needed for effective cooling at current operating conditions. As a result, windage losses and pumping power requirements in the machine are reduced, and machine efficiency is increased.

Abstract: The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. In a method aspect of the present invention, a method of forming an aerosol for use in inhalation therapy is provided. The method involves the following steps: (a) heating a substrate coated with a composition comprising a drug at a rate greater than 1000° C./s, thereby forming an vapor; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another method aspect of the present invention, a method of forming an aerosol for use in inhalation therapy is provided. The method involves the following steps: (a) heating a substrate coated with a composition comprising a drug to form a vapor, wherein the coated composition is in the form of a film less than 10 ? thick; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy.

Abstract: A set of contiguous and partially overlapping RNA sequences and polypeptides encoded thereby, designated as BS106 and transcribed from breast tissue is described. These sequences are useful for the detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the breast such as breast cancer. Also provided are antibodies which specifically bind to BS106-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific BS106 polypeptide, which molecules are useful for the therapeutic treatment of breast diseases, tumors or metastases.

Abstract: The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 ?m, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided. The device contained in the kit typically, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Also disclosed, are methods for using these aerosols and kits.

Abstract: A method of attaching a solder element to a contact and the contact assembly formed thereby. The contact assembly is used in a connector. The solder element is either staked or stapled to the contact. The solder element can take a variety of shapes and disclosed herein is a tear-drop shape, a “wolf's head” shape and a circular shape. An over-stress feature is also provided for when the contact assembly is mounted to a printed wiring board.

Abstract: An electric machine includes a fluid control system that is configured to regulate the flow rate of fluid to the electric machine. The machine includes a sensor that senses a parameter representative of cooling required by the machine. The sensor supplies a sensor signal to a control unit, which in turn supplies a flow control signal to a flow regulator. The flow regulator, in response to the flow control signal, controls the flow rate of fluid to the machine to what is needed for effective cooling at current operating conditions. As a result, windage losses and pumping power requirements in the machine are reduced, and machine efficiency is increased.

Abstract: Systems and methods for applying both profile and user customizations to an application user interface are provided. Profile customizations, created for a specialized use or field, are adapted to an application user interface, which has command-menu-toolbar contributions from various add-in modules. The user has access to the customizations through a user interface. Then, as a user is customizing the application, through commands, toolbars, and menus, the user customizations are tagged. A priority and group is assigned to each customization to allow for relative positioning of each customization. The difference between the user's final desired state and a reset state is computed. This difference computation is used to track the changes made to the application and to assist in resets of the customizations.

Abstract: The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1–3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 ?m, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided. The device contained in the kit typically, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Also disclosed, are methods for using these aerosols and kits.

Abstract: A set of contiguous and partially overlapping cDNA sequences and polypeptides encoded thereby, designated as CS198 and transcribed from GI tract tissue, is described. These sequences are useful for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the GI tract, such as GI tract cancer. Also provided are antibodies which specifically bind to CS198-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific CS198 polypeptide, which molecules are useful for the therapeutic treatment of GI tract diseases, tumors or metastases.

Abstract: A microemulsion composition having a solid source of peroxycarboxylic acid and germinant is used for chemical and biological warfare decontamination. A process for decontaminating uses the microemulsion composition.

Abstract: A method and system for retrieving and maintaining presentation data in a presentation cache is provided. In a preferred embodiment, a presentation cache object provides a presentation cache with multiple cache entries. Each entry contains an indication of the format of the presentation data and the presentation data stored in that particular format. In addition, other information, such as the advisees of advisory connections for notification of cache updates, can be maintained. The presentation cache object responds to requests for retrieving source object data by returning presentation data cached within the presentation cache when it is available. In addition, the presentation cache object determines when it should delegate requests to the source object and when it can satisfy them on its own. The presentation cache object can return presentation data to a requesting client program even if the server program implementing the source object is unavailable or not running.